SOPHiA GENETICS SA (SOPH) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jurgi Camblong

Executive Chairman

—

$61.67K (1) scheduled

−$61.67K

3,387,150

4.95%

$24.33M

+2.4%

Philippe Menu

Chief Medical Officer

—

$36.30K (1) scheduled

−$36.30K

195,993

0.2862%

$1.41M

+12.5%

Zhenyu Xu

Chief Scientific Officer

—

$28.73K (1) scheduled

−$28.73K

541,493

0.7907%

$3.89M

+0.7%

Ross Muken

Chief Executive Officer

—

660,391

0.9643%

$4.74M

+141.8%

Vincent Ossipow

Director

—

522,860

0.7635%

$3.76M

+3.9%

Well Daan Van

Chief Legal Officer

—

332,716

0.4858%

$2.39M

+27.0%

Troy Cox

Director

—

328,743

0.4800%

$2.36M

+6.4%

George Cardoza

Chief Financial Officer

—

306,726

0.4479%

$2.20M

+65.2%

Didier Hirsch

Director

—

240,220

0.3508%

$1.73M

+8.9%

Jean-Michel Cossery

Director

—

206,212

0.3011%

$1.48M

+10.6%

Manuela Valente

Chief People Officer

—

206,210

0.3011%

$1.48M

+35.0%

Abhimanyu Verma

Chief Technology Officer

—

166,887

0.2437%

$1.20M

+32.6%

Kevin Puylaert

Chief Sales Officer

—

147,732

0.2157%

$1.06M

+59.8%

Kathy L Hibbs

Director

—

96,992

0.1416%

$696.58K

−0.3%

SOPHiA GENETICS SA

What the insiders did Scheduled selling only

By person